121 related articles for article (PubMed ID: 33548920)
1. Commentary: Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case Studies.
Lukas RV
Neurosurgery; 2021 Mar; 88(4):E343-E344. PubMed ID: 33548920
[No Abstract] [Full Text] [Related]
2. Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case Studies.
Uluc K; Siler DA; Lopez R; Varallyay C; Netto JP; Firkins J; Lacy C; Huddleston A; Ambady P; Neuwelt EA
Neurosurgery; 2021 Mar; 88(4):E336-E342. PubMed ID: 33548921
[TBL] [Abstract][Full Text] [Related]
3. Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation.
McLaughlin ME; Robson CD; Kieran MW; Jacks T; Pomeroy SL; Cameron S
J Pediatr Hematol Oncol; 2003 Aug; 25(8):644-8. PubMed ID: 12902920
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
Nishio S; Morioka T; Takeshita I; Shono T; Inamura T; Fujiwara S; Fukui M
Clin Neurol Neurosurg; 1995 Nov; 97(4):300-6. PubMed ID: 8599896
[TBL] [Abstract][Full Text] [Related]
5. Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma.
Wasilewski A; Mohile N
CNS Oncol; 2018 Jul; 7(3):CNS26. PubMed ID: 29629823
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for pilocytic astrocytomas.
Brown MT; Friedman HS; Oakes WJ; Boyko OB; Hockenberger B; Schold SC
Cancer; 1993 May; 71(10):3165-72. PubMed ID: 8490847
[TBL] [Abstract][Full Text] [Related]
7. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.
Hunter S; Young A; Olson J; Brat DJ; Bowers G; Wilcox JN; Jaye D; Mendrinos S; Neish A
J Neuropathol Exp Neurol; 2002 Mar; 61(3):275-81. PubMed ID: 11895042
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin L silencing increases As
Primon M; Huszthy PC; Motaln H; Talasila KM; Miletic H; Atai NA; Bjerkvig R; Lah Turnšek T
Exp Cell Res; 2017 Jul; 356(1):64-73. PubMed ID: 28412241
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.
Kato T; Sawamura Y; Tada M; Ikeda J; Ishii N; Abe H
J Neurooncol; 1998 May; 37(3):263-70. PubMed ID: 9524084
[TBL] [Abstract][Full Text] [Related]
10. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
[TBL] [Abstract][Full Text] [Related]
12. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
13. An elderly patient presenting with a primary spinal multifocal intradural extramedullary pilocytic astrocytoma: a case report and review of the literature.
McBride D; Aljuboori Z; Hattab EM; Downs R; Woo S; Williams B; Neimat J; Burton E
BMC Cancer; 2018 Aug; 18(1):806. PubMed ID: 30092761
[TBL] [Abstract][Full Text] [Related]
14. Primary anaplastic pilocytic astrocytoma.
Azad A; Deb S; Cher L
J Clin Neurosci; 2009 Dec; 16(12):1704-6. PubMed ID: 19815416
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of high-grade astrocytomas.
Lesser GJ; Grossman S
Semin Oncol; 1994 Apr; 21(2):220-35. PubMed ID: 8153666
[No Abstract] [Full Text] [Related]
16. Altered expression of immune defense genes in pilocytic astrocytomas.
Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal dissemination of pilocytic astrocytoma in a 17-year-old boy.
Jandaghi AB; Bidabadi E; Saadat S; Alijani B; Daliri S; Reyhanian Z; Mashouf M
Turk Neurosurg; 2014; 24(6):978-81. PubMed ID: 25448220
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment on long-term survivors with malignant astrocytomas.
Imperato JP; Paleologos NA; Vick NA
Ann Neurol; 1990 Dec; 28(6):818-22. PubMed ID: 2178330
[TBL] [Abstract][Full Text] [Related]
20. Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.
Balasubramanian A; Gunjur A; Gan HK; Perchyonok Y; Cher LM
J Clin Neurosci; 2020 Sep; 79():269-271. PubMed ID: 33070910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
